Several grading systems for procedural risk in the endovascular treatment of brain arteriovenous malformations (AVMs) have been proposed, including the Buffalo, Puerto Rico, and AVM embocure scoring systems. The authors sought to validate these systems in an independent patient cohort and compare each system to the established Spetzler-Martin (SM) scale.
One hundred four consecutive patients underwent adjunctive endovascular embolization of brain AVMs between 2002 and 2016 with the goal of reducing the surgical or hemorrhagic risk before definitive radiosurgical treatment. Baseline clinical and AVM characteristics, complications, and degree of AVM nidus reduction were obtained retrospectively. Univariate and multivariate comparisons and receiver operating characteristic (ROC) curve analyses were performed.
Ten major (9.6%) and 16 minor (15.4%) complications were encountered in 24 patients (23.1%). An arterial pedicle size < 1 mm (p = 0.001) and a greater number of pedicles (p = 0.039) were predictors of complication occurrence. Only the Buffalo score predicted the complication rate on univariate (p = 0.039) and multivariate (p = 0.001) analyses. ROC curve analysis revealed a greater area under the curve (AUC) of the Buffalo score (0.703) compared to the Puerto Rico score (p = 0.028), AVM embocure score (AVMES; p = 0.010), and SM grade (SMG; p = 0.030). The Buffalo score, Puerto Rico score, and AVMES but not the SMG predicted > 85% nidus reduction. The AUCs for the different scoring systems were not significantly different.
The major complication rate of 9.6% is within the range of rates reported in the literature and emphasizes that brain AVM embolization is not a low-risk procedure. The Buffalo score but not the Puerto Rico score, AVMES, or SMG predicted the endovascular procedural risk. All three endovascular scores but not the SMG predicted a > 85% nidus reduction rate in this cohort embolized as part of a multimodal AVM treatment.
Al-Shahi SalmanR, WhitePM, CounsellCE, du PlessisJ, van BeijnumJ, JosephsonCB, : Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. 311:1661–1669, 201410.1001/jama.2014.3200)| false
FelicianoCEde León-BerraRHernández-GaitánMSRodríguez-MercadoR: A proposal for a new arteriovenous malformation grading scale for neuroendovascular procedures and literature review. P R Health Sci J29:117–1202010
FelicianoCE, de León-BerraR, Hernández-GaitánMS, Rodríguez-MercadoR: A proposal for a new arteriovenous malformation grading scale for neuroendovascular procedures and literature review. 29:117–120, 201020496526)| false
JinHJiangYGeHLuoJLiCWuH: Comparison of grading scales regarding perioperative complications and clinical outcomes of brain arteriovenous malformations after endovascular therapy-multicenter study. World Neurosurg106:394–4012017
MohrJPParidesMKStapfCMoqueteEMoyCSOverbeyJR: Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet383:614–6212014
MohrJP, ParidesMK, StapfC, MoqueteE, MoyCS, OverbeyJR, : Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. 383:614–621, 20142426810510.1016/S0140-6736(13)62302-8)| false
van BeijnumJ, van der WorpHB, BuisDR, Al-Shahi SalmanR, KappelleLJ, RinkelGJ, : Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. 306:2011–2019, 201110.1001/jama.2011.1632)| false